Cargando…
A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies
Huntington's disease (HD) is a fatal autosomal‐dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab developed a novel immune deficient HD mouse strain, the YACNSG,...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235129/ https://www.ncbi.nlm.nih.gov/pubmed/33710799 http://dx.doi.org/10.1002/sctm.20-0431 |
_version_ | 1783714244719542272 |
---|---|
author | Dahlenburg, Heather Cameron, David Yang, Sheng Bachman, Angelica Pollock, Kari Cary, Whitney Pham, Missy Hendrix, Kyle White, Jeannine Nelson, Haley Deng, Peter Anderson, Joseph S. Fink, Kyle Nolta, Jan |
author_facet | Dahlenburg, Heather Cameron, David Yang, Sheng Bachman, Angelica Pollock, Kari Cary, Whitney Pham, Missy Hendrix, Kyle White, Jeannine Nelson, Haley Deng, Peter Anderson, Joseph S. Fink, Kyle Nolta, Jan |
author_sort | Dahlenburg, Heather |
collection | PubMed |
description | Huntington's disease (HD) is a fatal autosomal‐dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab developed a novel immune deficient HD mouse strain, the YACNSG, from a commonly used line, the YAC128 mouse, to enable transplantation studies using engineered human cells in addition to studying the impact of the immune system on disease progression. The primary goal of this project was to characterize this novel immune deQficient HD mouse model, using behavioral assays and histology to compare this new model to the immune competent YAC128 and immune deficient mice that had engraftment of a human immune system. Flow cytometry was used to confirm that the YACNSG strain lacked immune cells, and in vivo imaging was used to assess human mesenchymal stem/stromal cell (MSC) retention compared with a commonly used immune deficient line, the NSG mouse. We found that YACNSG were able to retain human MSCs longer than the immune competent YAC128 mice. We performed behavioral assessments starting at 4 months of age and continued testing monthly until 12 months on the accelerod and in the open field. At 12 months, brains were isolated and evaluated using immunohistochemistry for striatal volume. Results from these studies suggest that the novel immune deficient YACNSG strain of mice could provide a good model for human stem‐cell based therapies and that the immune system appears to play an important role in the pathology of HD. |
format | Online Article Text |
id | pubmed-8235129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82351292021-06-29 A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies Dahlenburg, Heather Cameron, David Yang, Sheng Bachman, Angelica Pollock, Kari Cary, Whitney Pham, Missy Hendrix, Kyle White, Jeannine Nelson, Haley Deng, Peter Anderson, Joseph S. Fink, Kyle Nolta, Jan Stem Cells Transl Med Enabling Technologies for Cell‐based Clinical Translation Huntington's disease (HD) is a fatal autosomal‐dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab developed a novel immune deficient HD mouse strain, the YACNSG, from a commonly used line, the YAC128 mouse, to enable transplantation studies using engineered human cells in addition to studying the impact of the immune system on disease progression. The primary goal of this project was to characterize this novel immune deQficient HD mouse model, using behavioral assays and histology to compare this new model to the immune competent YAC128 and immune deficient mice that had engraftment of a human immune system. Flow cytometry was used to confirm that the YACNSG strain lacked immune cells, and in vivo imaging was used to assess human mesenchymal stem/stromal cell (MSC) retention compared with a commonly used immune deficient line, the NSG mouse. We found that YACNSG were able to retain human MSCs longer than the immune competent YAC128 mice. We performed behavioral assessments starting at 4 months of age and continued testing monthly until 12 months on the accelerod and in the open field. At 12 months, brains were isolated and evaluated using immunohistochemistry for striatal volume. Results from these studies suggest that the novel immune deficient YACNSG strain of mice could provide a good model for human stem‐cell based therapies and that the immune system appears to play an important role in the pathology of HD. John Wiley & Sons, Inc. 2021-03-12 /pmc/articles/PMC8235129/ /pubmed/33710799 http://dx.doi.org/10.1002/sctm.20-0431 Text en © 2021 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Enabling Technologies for Cell‐based Clinical Translation Dahlenburg, Heather Cameron, David Yang, Sheng Bachman, Angelica Pollock, Kari Cary, Whitney Pham, Missy Hendrix, Kyle White, Jeannine Nelson, Haley Deng, Peter Anderson, Joseph S. Fink, Kyle Nolta, Jan A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
title | A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
title_full | A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
title_fullStr | A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
title_full_unstemmed | A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
title_short | A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
title_sort | novel huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies |
topic | Enabling Technologies for Cell‐based Clinical Translation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235129/ https://www.ncbi.nlm.nih.gov/pubmed/33710799 http://dx.doi.org/10.1002/sctm.20-0431 |
work_keys_str_mv | AT dahlenburgheather anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT camerondavid anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT yangsheng anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT bachmanangelica anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT pollockkari anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT carywhitney anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT phammissy anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT hendrixkyle anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT whitejeannine anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT nelsonhaley anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT dengpeter anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT andersonjosephs anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT finkkyle anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT noltajan anovelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT dahlenburgheather novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT camerondavid novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT yangsheng novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT bachmanangelica novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT pollockkari novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT carywhitney novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT phammissy novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT hendrixkyle novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT whitejeannine novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT nelsonhaley novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT dengpeter novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT andersonjosephs novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT finkkyle novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies AT noltajan novelhuntingtonsdiseasemousemodeltoassesstheroleofneuroinflammationondiseaseprogressionandtodevelophumancelltherapies |